Yearly influenza vaccinations: a double-edged sword?BODEWES, Rogier; KREIJTZ, Joost H. C. M; RIMMELZWAAN, Guus F et al.Lancet. Infectious diseases (print). 2009, Vol 9, Num 12, pp 784-788, issn 1473-3099, 5 p.Article

The Multibasic Cleavage Site in H5N1 Virus Is Critical for Systemic Spread along the Olfactory and Hematogenous Routes in FerretsSCHRAUWEN, Eefje J. A; HERFST, Sander; FOUCHIER, Ron A. M et al.Journal of virology. 2012, Vol 86, Num 7, pp 3975-3984, issn 0022-538X, 10 p.Article

Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccineVAN DE SANDT, Carolien E; KREIJTZ, Joost H. C. M; GEELHOED-MIERAS, Martina M et al.Vaccine. 2014, Vol 32, Num 43, pp 5614-5623, issn 0264-410X, 10 p.Article

Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in FerretsVAN DEN BRAND, Judith M. A; KREIJTZ, Joost H. C. M; RIMMELZWAAN, Guus F et al.Journal of virology. 2011, Vol 85, Num 6, pp 2851-2858, issn 0022-538X, 8 p.Article

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1KREIJTZ, Joost H. C. M; SUEZER, Yasemin; SUTTER, Gerd et al.The Journal of infectious diseases. 2007, Vol 195, Num 11, pp 1598-1606, issn 0022-1899, 9 p.Article

Pathogenesis of Influenza A/H5N1 Virus Infection in Ferrets Differs between Intranasal and Intratracheal Routes of InoculationBODEWES, Rogier; KREIJTZ, Joost H. C. M; VAN AMERONGEN, Geert et al.The American journal of pathology. 2011, Vol 179, Num 1, pp 30-36, issn 0002-9440, 7 p.Article

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H 1 N 1 vaccine in the ferret modelKREIJTZ, Joost H. C. M; SÜZER, Yasemin; FOUCHIER, Ron A. M et al.Journal of general virology. 2010, Vol 91, pp 2745-2752, issn 0022-1317, 8 p., 11Article

Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trialKREIJTZ, Joost H. C. M; GOEIJENBIER, Marco; FOUCHIER, Ron A. M et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 12, pp 1196-1207, issn 1473-3099, 12 p.Article

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cellsHILLAIRE, Marine L. B; VAN TRIERUM, Stella E; KREIJTZ, Joost H. C. M et al.Journal of general virology. 2011, Vol 92, pp 2339-2349, issn 0022-1317, 11 p., 10Article

Recombinant Soluble, Multimeric HA and NA Exhibit Distinctive Types of Protection against Pandemic Swine-Origin 2009 A(H1N1) Influenza Virus Infection in FerretsJAN BOSCH, Berend; BODEWES, Rogier; DE VRIES, Robert P et al.Journal of virology. 2010, Vol 84, Num 19, pp 10366-10374, issn 0022-538X, 9 p.Article